In this article, we will discuss: 12 Best Marijuana Stocks to Buy According to Analysts. Marijuana stocks, frequently known as cannabis stocks, are publicly traded firms that operate in the legal ...

We recently published 10 Best Small-Cap Stocks With Huge Potential According to Reddit as Market Looks Beyond AI Trade. High ...

Tilray Brands, Indivior, and Turning Point Brands are the three Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis stocks are shares of publicly traded companies ...

SHF, Tilray Brands, Canopy Growth, Cronos Group, and SNDL are the five Cannabis stocks to watch today, according to MarketBeat’s stock screener tool. Cannabis stocks are the publicly traded shares of ...

Dividend stocks remain a popular vehicle for income-oriented investors, offering the dual appeal of regular cash flow plus ...

Tilray, unsurprisingly, has given back a good chunk of its gains in recent weeks, and it's now down more than 50% from its 52 ...

Cannabis stocks once soared to billion-dollar valuations, but now trade at penny stock levels after the hype faded. 40 U.S. states allow medical marijuana, 24 permit recreational use, yet federal ...

Tilray Brands surged nearly 20% and was up 36% after market open, while Canopy Growth jumped about 20% and Cronos Group rose 13%. Aurora Cannabis climbed 13.3%, and Trulieve Cannabis — one of Wall ...

Sept 29 (Reuters) - Shares of pot companies rose on Monday after U.S. President Donald Trump advocated the potential benefits from the use of cannabidiol in senior healthcare in a social media post, ...

A group of American public legal officials expressed concern about current federal law covering hemp. They feel that although it was legalized in 2018, it's only poorly defined in federal law. The ...

How well did marijuana stocks fare in 2017? It depends. Previous high-flying cannabinoid-focused biotech stocks didn't generate a lot of excitement for investors this year. Neither did most U.S.-based ...

Canopy Growth Corporation (NASDAQ:CGC) released Q1 FY2026 net revenue of $72.1M, up 9% year-over-year. This growth was fuelled by a 13% rise in medical cannabis sales and a 43% increase in adult-use ...